IRIS
MICALE, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.953
EU - Europa 2.096
AS - Asia 1.913
SA - Sud America 392
AF - Africa 174
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 8.533
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.789
SG - Singapore 1.008
RU - Federazione Russa 714
CN - Cina 572
IT - Italia 463
IE - Irlanda 362
BR - Brasile 335
UA - Ucraina 158
CA - Canada 139
CI - Costa d'Avorio 107
VN - Vietnam 95
GB - Regno Unito 65
IN - India 62
DE - Germania 61
KR - Corea 58
ES - Italia 43
SE - Svezia 43
NL - Olanda 34
FI - Finlandia 29
CZ - Repubblica Ceca 28
SN - Senegal 27
PL - Polonia 24
TR - Turchia 20
AR - Argentina 18
MX - Messico 18
JP - Giappone 16
FR - Francia 15
ZA - Sudafrica 14
ID - Indonesia 13
BD - Bangladesh 12
EC - Ecuador 12
CH - Svizzera 10
IQ - Iraq 10
HK - Hong Kong 9
VE - Venezuela 8
AT - Austria 7
BE - Belgio 7
CO - Colombia 7
GR - Grecia 7
LB - Libano 7
NG - Nigeria 7
DK - Danimarca 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
BJ - Benin 5
PK - Pakistan 5
UZ - Uzbekistan 5
EU - Europa 4
IR - Iran 4
AZ - Azerbaigian 3
CL - Cile 3
LT - Lituania 3
PE - Perù 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
BB - Barbados 2
BO - Bolivia 2
KZ - Kazakistan 2
RS - Serbia 2
AL - Albania 1
AU - Australia 1
BH - Bahrain 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
LV - Lettonia 1
MA - Marocco 1
MU - Mauritius 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SM - San Marino 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
ZW - Zimbabwe 1
Totale 8.533
Salva come PNG Salva come JPEG
Città #
Santa Clara 758
Dallas 646
Singapore 570
Dublin 344
Chandler 300
Moscow 253
Jacksonville 234
Chicago 201
Boardman 139
Ashburn 133
Hefei 115
Catania 110
Abidjan 107
San Jose 100
Cambridge 92
Lawrence 92
Andover 90
Nanjing 85
Toronto 83
Los Angeles 72
Des Moines 64
Seoul 58
Beijing 50
Houston 43
New York 40
Civitanova Marche 35
Ho Chi Minh City 32
Nanchang 32
Hebei 30
Messina 28
Ottawa 28
São Paulo 28
Dakar 27
Amsterdam 26
Hyderabad 25
Rome 25
Saint Petersburg 24
Shenyang 22
Tianjin 22
Changsha 21
Hanoi 21
Prague 21
Munich 20
Jiaxing 19
Brooklyn 18
Council Bluffs 18
San Mateo 18
Wilmington 18
Barcelona 17
Warsaw 16
Orem 15
Poplar 15
Buffalo 14
Tokyo 14
Lappeenranta 13
Montreal 13
Columbus 12
Denver 12
The Dalles 12
Johannesburg 11
Palermo 11
Seattle 11
Atlanta 10
Chennai 10
Phoenix 10
Zhengzhou 10
Belo Horizonte 9
Florence 9
Jinan 9
San Francisco 9
Augusta 8
Boston 8
Manchester 8
Abuja 7
Ankara 7
Brussels 7
Dong Ket 7
Hong Kong 7
Mumbai 7
Stockholm 7
Turku 7
Berlin 6
Guangzhou 6
Haiphong 6
Helsinki 6
Istanbul 6
Jakarta 6
London 6
Madrid 6
Redwood City 6
Rio de Janeiro 6
Secaucus 6
Aci Catena 5
Bremen 5
Cotonou 5
Foggia 5
Hangzhou 5
Ningbo 5
Ribeirão Preto 5
Shanghai 5
Totale 5.785
Salva come PNG Salva come JPEG
Nome #
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 150
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 137
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems 131
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets 124
Fluoxetine Protects Retinal Ischemic Damage in Mice 123
Behavioral effects of the β3 adrenoceptor agonist SR58611A: Is it the putative prototype of a new class of antidepressant/anxiolytic drugs? 121
Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks 120
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels 119
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 118
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 117
The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes 117
Altro che Marijuana : i molteplici ruoli delle sostanze cannabinoidi endogene 115
Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions 114
Beavioral effects of SR 58611A, a beta-3 agonist, on experimental models of mild stress 112
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: analyses in patients and perinatal Δ9-tetrahydrocannabinol-exposed rats 112
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 111
Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade 111
Amnesia induced by beta-amyloid peptide in dopamine D3 knock-out (KO) mice Is affectedby a cannabinoid CB1 receptor antagonist 110
Behavioral modifications induced by dietary cholesterol in rats 109
Systemic depletion of histone macroH2A1.1 boosts hippocampal synaptic plasticity and social behavior in mice 109
Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats 107
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology 105
Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats 104
Behavioral and molecular effects of repeated treatment with citalopram alone or combined with memantine in rats 103
Attuali orientamenti terapeutici della malattia di Parkinson 102
Early modulation of the endocannabinoid tone prevents molecular and behavioral alterations in MAM model of schizophrenia 102
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis 101
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels 101
null 101
Behavioral effects of ABIO 09/01, a CaMKII inhibitor, on experimental models of depression and anxiety 100
Endocannabinoids and neurodegenerative diseases 94
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons 94
The cannabinoid CB1 antagonist TM38837 with limited penetrance to the brain shows reduced fear-promoting effects in mice 93
Cannabidiol and the central nervous system: translating into clinics 91
Red Flags in Primary Mitochondrial Diseases: What Should We Recognize? 90
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 89
The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats 88
Melatonin affects the immobility time of rats in the forced swim test: The role of serotonin neurotransmission 87
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia 84
Cannabinoid CB1 receptor blockade effects memory capacity of dopamine D3 KO mice pre-treated with β-amyloid peptide 83
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia 81
Dopamine D(3) receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam 79
Effects of citalopram combined with memantine in forced swimming test in rats 78
Therapeutic potential of cannabinoids in schizophrenia 77
Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats 76
“Prescription pattern of antiepileptics in primary care in Italy upon recognition of new indications for reimbursement“. 76
Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment 75
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 74
Prenatal Exposure to Δ9-Tetrahydrocannabinol Affects Hippocampus-Related Cognitive Functions in the Adolescent Rat Offspring: Focus on Specific Markers of Neuroplasticity 73
Long-lasting neurotoxicity of prenatal benzene acute exposure in rats 73
Sex Differences in the Reinstatement of Methamphetamine Seeking after Forced Abstinence in Sprague-Dawley Rats 73
Biocompatibility of a genetically encoded calcium indicator in a transgenic mouse model 73
Dual effects of melatonin on barbiturate-induced narcosis in rats 73
Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus 73
Involvement of NK2 receptors in experimental models of anxiety and depression under basal and stress-related conditions 72
Use of phenylethanolaminotetralines for preparing anxiolytic drugs 72
Topically administered NOX4 inhibitor, GLX7013114, is efficacious in treating the early pathological events of diabetic retinopathy 71
Role of the endocannabinoid system and vanilloid TRPV1 channels in the phenotype of dopamine D3 receptor knock-out mice 71
HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals 71
Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors 70
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 70
D3 dopamine receptor knockout mice: behavioral alteration in experimental models of anxiety 70
Placebo affects the performance of rats in models of depression: is it a good control for behavioral experiments? 70
DNA methylation at cannabinoid type 1 and dopamine D2 receptor genes in saliva samples of psychotic subjects: Is there an effect of Cannabis use? 69
Dynamic DNA methylation programs persistent adverse effects of early-life stress 69
Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test) 69
Binge-like alcohol exposure in adolescence: behavioural, neuroendocrine and molecular evidence of abnormal neuroplasticity … and return 69
Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon? 68
Parkin expression profile in dopamine d3 receptor knock-out mice brains 68
Dysregulation of endocannabinoid system in schizophrenia: the potential role of cannabinoid 1 receptor altered gene expression 68
Vitamin D and depression in women: a mini-review 68
The amnesic effects induced by β-amyloidfragment 1–42 involve cannabinoid neurotransmission in the brain 67
Dopaminergic drugs may counteract behavioral and biochemical changes induced by models of brain injury 66
Endocannabinoid system and mood disorders: Priming a target for new therapies 66
Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue 66
Increased sensitivity to antidepressants of D(3) dopamine receptor-deficient mice in the forced swim test (FST) 65
Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia 65
Lack of interaction of endocannabinoids and 5-HT(3) neurotransmission in associative fear circuits of the amygdala: evidence from electrophysiological and behavioural experiments 65
Hippocampal neuroplasticity is involved in the antidepressant-like effects of 5HT4 receptor partial agonist SL 65.0155 64
The beta3 adrenoceptor agonist amibegron counteracts stress-induced behavioural and neurobiological changes 64
Increased levels of conditioned fear and avoidance behavior coincide with changes in phosphorylation of the protein kinase B (AKT) within the amygdala in a mouse model of extremes in trait anxiety 64
Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat model 63
Endocannabinoid system genes regulation in schizophrenia 63
Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects 63
Deficiency of histone variant macroH2A1.1 is associated with sexually dimorphic obesity in mice 62
Prolonged fear incubation leads to generalized avoidance behavior in mice 62
Signaling through cGMP-dependent protein kinase I in the amygdala is critical for auditory-cued fear memory and long-term potentiation 62
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors. 62
Prenatal influences facilitate the precipitation of a schizophrenia-like phenotype: assessing the role of the endocannabinoid system 62
Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems 62
Leading compounds for the validation of animal models of psychopathology 60
Structural and behavioural changes in a rodent developmental disruption model of schizophrenia 60
Endocannabinoid system, stress and HPA axis 60
Memory performance of dopamine D3 knock-out mice (KO) mice pre-treated with beta-amyloid peptide is affected by cannabinoid CB1 receptor antagonist 59
Role of the Endocannabinoid System in Depression: from Preclinical to Clinical Evidence 59
Cognitive effects of SL650155, a 5HT4 receptor partial agonist, in animal models of amnesia 58
Olanzapine, but not haloperiool, improves cognitive performance in an animal model of amnesia induced by β-amyloid peptides 57
Early pharmacological modulation of the endogenous cannabinoid signaling counteracts the phenotype in a rodent developmental disruption model of schizophrenia at adulthood 57
Use of phenylethanolaminotetralines for preparing anxiolytic drugs 56
Parkin expression in dopamine D3 receptor Knock out mice 56
Totale 8.333
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.375
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021162 0 0 0 0 0 0 64 6 21 7 44 20
2021/2022661 91 89 7 23 99 11 95 35 32 2 12 165
2022/20231.050 97 49 12 84 87 186 10 184 262 3 42 34
2023/2024444 31 67 26 32 18 53 4 14 34 17 92 56
2024/20252.327 30 334 127 119 575 352 41 82 162 178 145 182
2025/20263.088 285 192 774 311 611 801 114 0 0 0 0 0
Totale 8.730